Adjunctive Therapy with Chinese Herbal Medicine Lowers Risk of Hearing Loss in Type 2 Diabetes Patients: Results from a Cohort-Based Case-Control Study
Open Access
- 10 September 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (9) , 1191
Abstract
Hearing loss is a frequently observed complication of type 2 diabetes (T2D). Emerging evidence has found that Chinese herbal medicine (CHM) can effectively treat chronic disease; nevertheless, it is unclear if adding CHM to the routine management of T2D would modify sequent risk of hearing loss. This cohort-based case-control study was conducted to address this issue. First, a total of 64,418 subjects aged 20–70 years, diagnosed with T2D between 2002 and 2011, were extracted from a nationwide health claims database. Among them, we identified 4516 cases of hearing loss after T2D by the end of 2013. They were then randomly matched to 9032 controls without hearing loss at a 1:2 ratio. Following conditional logistic regression, we found the addition of CHM to conventional care reduced the risk of developing hearing loss, with an adjusted odds ratio of 0.75 (95% confidence interval: 0.70–0.83). Specifically, taking CHM products for at least two years benefits T2D patients in lowering sequent risk of hearing loss. The findings herein implicated that integrating CHM into conventional care substantially correlated to lower risk of hearing loss for T2D patients, but further basic research is needed to secure the application of finished herbal products.Keywords
This publication has 37 references indexed in Scilit:
- Association between hearing loss and suicidal ideation: Discrepancy between pure tone audiometry and subjective hearing levelJournal of Affective Disorders, 2023
- Ban-xia-xie-xin-tang ameliorates hepatic steatosis by regulating Cidea and Cidec expression in HFD-fed micePhytomedicine, 2022
- Oxidative stress in the pathophysiology of type 2 diabetes and related complications: Current therapeutics strategies and future perspectivesFree Radical Biology and Medicine, 2022
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045Diabetes Research and Clinical Practice, 2022
- Pingwei San ameliorates dextran sulfate sodium-induced chronic colitis in miceJournal of Ethnopharmacology, 2019
- The role of acetylcholinesterase inhibitors such as neostigmine and rivastigmine on chronic pain and cognitive function in aging: A review of recent clinical applicationsAlzheimer's & Dementia: Translational Research & Clinical Interventions, 2019
- Magnolol attenuates the inflammation and enhances phagocytosis through the activation of MAPK, NF-κB signal pathways in vitro and in vivoMolecular Immunology, 2019
- Chronic inflammation – inflammaging – in the ageing cochlea: A novel target for future presbycusis therapyAgeing Research Reviews, 2017
- Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: A nationwide database studyJournal of Ethnopharmacology, 2015
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992